Actinic Keratoses: Clinical Trials

16 trials for Actinic Keratoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 1 not yet recruiting, 1 terminated. 16 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 316Completed 14, Not yet recruiting 1, Terminated 1

Follow Actinic Keratoses: new trials by email Literature Review of Actinic Keratoses trials Research Report on Actinic Keratoses

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead
Cryotherapy + Tirbanibulin - Keratosis, Actinic Keratoses
Phase 3Not yet recruitingUniversity Hospital, Lille592026-11-302026-05-22
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
BF-200 ALA and red light LED lamp, Vehicle and red light LED lamp - Actinic Keratoses
Phase 3CompletedBiofrontera Inc.1722022-12-122026-08-21
Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis
Test Product (A): Fluorouracil Cream, 5% topical cream, Reference Product (B): Fluorouracil 5% Topical Cream of Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Placebo Product (C): Test vehicle cream for fluorouracil 5% of Encube Ethicals Pvt. Ltd., India - Actinic Keratoses
Phase 3CompletedEncube Ethicals Pvt. Ltd.4582022-03-012023-03-14
Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face
MAL 16.8% cream, MAL Vehicle Cream - Actinic Keratoses
Phase 3CompletedGalderma R&D5572019-09-302022-04-01
Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis
Diclofenac Sodium Gel, Solaraze 3% Topical Gel, Placebo - Actinic Keratoses
Phase 3CompletedEncube Ethicals Pvt. Ltd.6552018-01-122019-02-01
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp
Placebo, KX2-391 Ointment 1% - Actinic Keratoses
Phase 3CompletedAlmirall, S.A.3512017-09-182021-04-13
Actinic Keratoses Treatment With Metvix® in Combination With Light
Metvix®, Photodynamic Therapy Blue light, Photodynamic Therapy Daylight - Actinic Keratoses
Phase 3CompletedUniversity Hospital, Limoges262015-03-252025-07-29
Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses
NDL-PDT, c-PDT, placebo c-PDT - Actinic Keratoses
Phase 3CompletedGalderma R&D1312013-07-012021-02-18
Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses
Metvix and natural daylight PDT, Metvix and conventional PDT - Actinic Keratoses
Phase 3CompletedGalderma R&D1002012-03-012021-02-18
Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients
MD-3511356, Standard Sun Protection Measures - Actinic Keratoses, Squamous Cell Carcinomas
Phase 3TerminatedSpirig Pharma Ltd.2442010-11-012016-01-08
Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo
Brand Carac, Generic 0.5% 5-fluorouracil cream, Placebo cream - Actinic Keratoses
Phase 3CompletedSpear Pharmaceuticals3772010-09-012014-10-20
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
PEP005 (ingenol mebutate) Gel, Vehicle gel - Actinic Keratoses
Phase 3CompletedPeplin2032009-07-012015-03-06
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
PEP005 (ingenol mebutate) Gel, Vehicle gel - Actinic Keratoses
Phase 3CompletedPeplin2552008-09-012015-03-06
Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis
imiquimod, Aldara™, Vehicle Cream - Actinic Keratoses
Phase 3CompletedActavis Inc.4622008-05-012020-09-04
Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
imiquimod cream, Placebo - Actinic Keratoses
Phase 3CompletedGraceway Pharmaceuticals, LLC4792008-01-012010-06-29
Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses
imiquimod - Actinic Keratoses
Phase 3CompletedUniversity of British Columbia202005-02-012006-05-09

Narrower conditions

Keratosis, Actinic (16)  ·  Carcinoma, Squamous Cell (2)  ·  Keratosis (2)  ·  Precancerous Conditions (2)  ·  Skin Diseases (2)  ·  Neoplasms (1)

Broader conditions

Skin and Connective Tissue Diseases (16)  ·  Neoplasms (15)  ·  Keratosis (14)  ·  Precancerous Conditions (14)  ·  Skin Diseases (14)  ·  Carcinoma (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Squamous Cell (2)

Interventions

Gels (3)  ·  3-ingenyl angelate (2)  ·  Fluorouracil (2)  ·  Imiquimod (2)  ·  methyl 5-aminolevulinate (2)  ·  BF-200 ALA (1)  ·  Cryotherapy (1)  ·  Diclofenac (1)  ·  Drugs, Generic (1)  ·  Photochemotherapy (1)  ·  tirbanibulin (1)

Sponsors

Galderma R&D (3)  ·  Encube Ethicals Pvt. Ltd. (2)  ·  Peplin (2)  ·  Actavis Inc. (1)  ·  Almirall, S.A. (1)  ·  Biofrontera Inc. (1)  ·  Graceway Pharmaceuticals, LLC (1)  ·  Spear Pharmaceuticals (1)  ·  Spirig Pharma Ltd. (1)  ·  University Hospital, Lille (1)  ·  University Hospital, Limoges (1)  ·  University of British Columbia (1)

Countries

United States (9)  ·  France (3)  ·  Australia (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Austria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Ireland (1)  ·  Puerto Rico (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Bibiana Perez Garcia, MD (1)  ·  Christine M. Winslow, Ph.D. (1)  ·  Claas Ulrich, MD (1)  ·  Ingrid Synnerstad, PhD, MD (1)  ·  Jane Fang, MD (1)  ·  Jason K Rivers, M.D. (1)  ·  Melanie Appell, M.D. (1)  ·  Nathalie Zeitouni, MD (1)  ·  Nicole Basset Seguin, PhD, MD (1)  ·  Rianne Gerritsen, PhD, MD (1)  ·  Rolf-Markus Sziemies, PhD, MD (1)  ·  Sharon F Levy, MD (1)  ·  Stephen Shumack (1)

Results publications

PMID 22417254, PMID 20133013, PMID 31955461, PMID 33567191